Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria's (MO) third-quarter 2020 results reflect strong pricing in smokeable and oral tobacco product segments. Management lifts the lower end of its previously guided earnings view.

Altria's (MO) Q3 Earnings Surpass Estimates on Solid Pricing

U.S. cigarette industry volume declines continued to stabilise in Q3, with the e-vapor threat receding and COVID-19 seemingly a positive. On an adjusted basis, Altria's cigarette volumes were down only 1% year-on-year for Q3, and only 2% year-to-date.

Altria: With Strong Q3 Results, This Stock Could Double By 2023 Year-End

It's a long way down for an e-cig maker that held such promise.

Altria's Juul Investment Devalued to Just $1.6 Billion

Altria (MO) delivered earnings and revenue surprises of 3.48% and 2.84%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Altria (MO) Tops Q3 Earnings and Revenue Estimates

  Shares of Altria Group (NYSE:MO) rose 0.6% in pre-market trading after the company reported Q3 results.

Altria Group: Q3 Earnings Insights

Altria Group Inc said on Friday it took a $2.6 billion charge on its investment in Juul Labs Inc in the third quarter, mainly due to lower revenue projection from the e-cigarette maker.

Marlboro maker Altria takes $2.6 billion third-quarter hit on Juul investment

RICHMOND, Va.--(BUSINESS WIRE)--Altria Group, Inc. (Altria) (NYSE:MO) announces that Dr. Ellen R. Strahlman will join its Board of Directors on November 2, 2020. Dr. Strahlman served as Executive Vice President, Research & Development and Chief Medical Officer of Becton, Dickinson and Company, a leading global medical technology company, from April 2013 until her retirement in January 2018. Before joining Becton Dickinson and Company, she served as a Senior Advisor to the CEO at GlaxoSmithK

Dr. Ellen R. Strahlman Elected to Altria's Board of Directors

RICHMOND, Va.--(BUSINESS WIRE)-- #2020guidance--Altria Group, Inc. (Altria) (NYSE: MO) today announces its 2020 third-quarter and nine-months business results and narrows its 2020 adjusted diluted earnings per share (EPS) guidance. “Altria continued to demonstrate its resilience during the third quarter while navigating the challenges presented by the COVID-19 pandemic,” said Billy Gifford, Altria's Chief Executive Officer. “In the third quarter, our tobacco businesses delivered strong financial performance on

Altria Reports 2020 Third-Quarter and Nine-Months Results; Tobacco Businesses Demonstrate Resilience; Narrows 2020 Full-Year Earnings Guidance

Shares of Altria Group Inc. rose 0.8% in premarket trading Friday, after the Marlboro cigarettes parent reported a narrower net loss, while the adjusted profit and revenue beat expectations. The net loss was $952 million, or 51 cents a share, after a loss of $2.60 billion, or $1.39 a share, in the year-ago period.

Altria records $2.6 billion charge on JUUL investment, but adjusted profit tops expectations

Juul's valuation took a big hit Thursday. Since tobacco company Altria Group acquired a large stake in Juul Labs, the vape manufacturer has struggled with regulatory issues and has seen its valuation fall several times.

Juul Group Cuts Valuation To $10B, Sinking Altria's Investment Further

Kraft Heinz

Bunge Global SA

Chevron

General Mills

Kinder Morgan

Philip Morris

AT&T

Verizon

Verizon Communications Inc 5.9 % Notes 2014-15.2.54 Sr

Exxon Mobil

In this article we present the list of 10 best high dividend stocks to buy now. Click to skip ahead and see the top 5 high dividend stocks to buy .

10 Best High Dividend Stocks To Buy Now

Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at delivering attractive risk-adjusted returns rather than following the ups and downs of equity markets hoping that they will outperform the broader market. Our research shows that certain hedge funds do have great stock picking skills (and we can identify these hedge funds in advance pretty accurately), so let's take a glance at the smart money sentiment towards Altria Group Inc (NYSE:MO).

Were Hedge Funds Right About Getting Out Of Altria Group Inc (MO)?

Altria (MO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Altria (MO) Might Surprise This Earnings Season

Canopy Growth

Constellation Brands

Tilray Brands

The U.S. election could be a bullish catalyst for marijuana stocks. However, a "blue wave" would be better for certain stocks than others.

Ranking the ‘Big 4' Canadian Marijuana Stocks From Best to Worst

CVS Health

Teva Pharmaceutical

4 Top Value Stocks on Sale to Buy Right Now

Altria's (MO) third-quarter 2020 results are likely to reflect gains from pricing and strength in oral tobacco products. However, cigarette volumes have been soft for a while.

Altria (MO) to Report Q3 Earnings: What's in the Offing?

Altria (MO) closed at $38.57 in the latest trading session, marking a -1.31% move from the prior day.

Altria (MO) Stock Moves -1.31%: What You Should Know

General Dynamics

Gilead Sciences

I have added to my taxable account 45.9168 shares at $27.00 for a total investment of $1,239.75 in AT&T Inc. I have added to my taxable account 17.7940 shares at $39.33 for a total investment of $699.83 in Altria Group, Inc.

Recent Stock Purchase October 2020

AbbVie

Aflac

Johnson & Johnson

Realty Income Corp

Walgreens

Coronavirus cases around the globe are rising, especially in Europe. This could pressure global economies, as lockdowns are more likely. Some countries in Europe have already enacted such measures again.

COVID Surges Again: Here Are 7 Resilient, Low-Risk Dividend Aristocrats To Prepare Your Portfolio

Colgate-Palmolive

Coca-Cola

Procter & Gamble

The true definition of dividend growth investing is quite clear, but I am finding plenty of folks here really do not understand it.

Retirement Strategy: What Does Dividend Growth Investing Actually Mean?

Carlisle Companies

Sanofi

4 Blue Chips To Sleep Well At Night In These Uncertain Times

RICHMOND, Va.--(BUSINESS WIRE)--Altria Group, Inc. (Altria) (NYSE: MO) will host a live audio webcast on Friday, October 30, at 9:00 a.m. Eastern Time to discuss its 2020 third-quarter business results. Altria will issue a press release containing its business results at approximately 7:00 a.m. Eastern Time the same day. The webcast can be accessed at altria.com or through the Altria Investor App. During the webcast, Billy Gifford, Altria's Chief Executive Officer, and Sal Mancuso, Chief Financ

Altria to Host Webcast of 2020 Third-Quarter Results

Altria (MO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why Altria (MO) Could Beat Earnings Estimates Again

British American Tobacco

Tobacco stocks are screening incredibly attractively, but regulatory, balance sheet and sustainability issues are plaguing the sector.

Mirror Mirror On The Wall, Which Tobacco Stock Is The Fairest Of Them All.

Best Buy

Pacer US Cash Cows 100 ETF

Discovery

Intel

Kroger

Lennar

Target

Tyson Foods

One way to find undervalued stocks is to use free cash flow yield as a barometer. Here are 10 stocks to buy based on this criterion.

News for Altria Stock (MO)